Interaction between polymorphisms in the renin-angiotensin-system and angiotensin-converting enzyme inhibitor or β-blocker use and the risk of myocardial infarction and stroke

2008-11-24

The Pharmacogenomics Journal , Volume 8 - Issue 6 p. 400- 407

Additional Metadata
Persistent URL	doi.org/10.1038/sj.tpj.6500493, hdl.handle.net/1765/58694
Journal	The Pharmacogenomics Journal
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Schelleman, H., Klungel, O., Witteman, J., Breteler, M., Hofman, A., van Duijn, C., … Stricker, B. (2008). Interaction between polymorphisms in the renin-angiotensin-system and angiotensin-converting enzyme inhibitor or β-blocker use and the risk of myocardial infarction and stroke. The Pharmacogenomics Journal, 8(6), 400–407. doi:10.1038/sj.tpj.6500493

Publication